Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 13, 2026

State of the Art Cranial Ultrasound Imaging in Neonates
10:02

State of the Art Cranial Ultrasound Imaging in Neonates

Published on: February 2, 2015

Structures for clinical follow-up: newborn screening.

R Rodney Howell1, Gilian Engelson

  • 1Department of Pediatrics, Miller School of Medicine, University of Miami, P.O. Box o16820, Miami, FL 33101, USA. rhowell@miami.edu

Journal of Inherited Metabolic Disease
|August 19, 2007
PubMed
Summary

Clinical follow-up for infants identified through newborn screening is crucial. Establishing a systematic, nationwide process ensures consistent, timely, and effective care for all infants, improving health outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Newborn Screening-A Worldwide Endeavour to Protect.

International journal of neonatal screening·2025
Same author

ISNS General Guidelines for Neonatal Bloodspot Screening 2025.

International journal of neonatal screening·2025
Same author

Whole-genome sequencing holds the key to the success of gene-targeted therapies.

American journal of medical genetics. Part C, Seminars in medical genetics·2022
Same author

The Progress and Future of US Newborn Screening.

International journal of neonatal screening·2022
Same author

Ethical Issues Surrounding Newborn Screening.

International journal of neonatal screening·2021
Same author

Duchenne Muscular Dystrophy Newborn Screening, a Case Study for Examining Ethical and Legal Issues for Pilots for Emerging Disorders: Considerations and Recommendations.

International journal of neonatal screening·2020

Area of Science:

  • Public Health
  • Pediatrics
  • Genetics

Background:

  • Clinical follow-up is vital for managing newborn infants identified via newborn screening.
  • Significant challenges exist in the U.S. newborn screening program, including inconsistent follow-up practices and protocols among states.
  • There is a need for a systematic approach to newborn follow-up care and a national infrastructure for consistent treatment.

Purpose of the Study:

  • To advocate for a systematic process for clinical follow-up of infants identified through newborn screening.
  • To emphasize the need for a nationwide infrastructure to ensure consistent and effective treatment for all infants.
  • To highlight the importance of structured follow-up for studying natural history, monitoring outcomes, validating screening, and advancing therapies.

Main Methods:

Related Experiment Videos

Last Updated: Jul 13, 2026

State of the Art Cranial Ultrasound Imaging in Neonates
10:02

State of the Art Cranial Ultrasound Imaging in Neonates

Published on: February 2, 2015

  • This study is a review and synthesis of current challenges and recommendations for newborn screening follow-up.
  • It analyzes variations in state practices and treatment protocols.
  • It proposes the development of a structured, nationwide clinical follow-up system.

Main Results:

  • Current newborn screening follow-up practices in the U.S. are inconsistent across states.
  • There is a lack of standardized diagnostic and treatment protocols among healthcare providers.
  • A structured, nationwide follow-up system is proposed as essential for optimal infant care.

Conclusions:

  • A structured clinical follow-up system is necessary to ensure equitable and effective care for all infants identified through newborn screening.
  • Such a system will facilitate research into disease natural history, outcomes, and the development of new interventions.
  • Implementing a nationwide infrastructure is key to advancing the clinical management of screened conditions.